Immunohistochemistry Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Product (Antibodies, Equipment, Reagents, Kits), By Application (Diagnostics, Drug Testing, Forensic applications), By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others), By Region and By Competition

Industry : Healthcare
Pages : NA
Published Date : NA

Customization Enquiry

Buy Now

Single User Licence

$4500

Multi-User Licence

$5500

Custom Research Licence

$8000

Summary

Request Sample

Report Description

Global Immunohistochemistry market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the rising demand for implementation of automation and machine learning in immunohistochemistry along with introduction of technologically advanced immunohistochemistry solutions across the globe. Moreover, rise in product approvals and the launch of technologically advanced IHC systems for diseases diagnosis are further driving the growth of the market during the forecast period. Similarly, growing research and development expenditures in the pharmaceutical and biotechnology industries are the major factors driving the growth of the market. Moreover, growing preference for personalized medicine, cancer genomics studies, and increasing patient engagement requirements is expected to drive the demand for the market during the forecast period. Similarly, growing usage of antibodies in the pathology, neuropathology, and hematopathology is expected to further enhance the demand for immunohistochemistry market during the forecast period. In August 2021, the FDA approved Roche’s VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy.

Growing Prevalence of Chronic Diseases

The growing prevalence of cancer along with increasing geriatric population is one of the major factors which is expected to further boost the growth of the market during the forecast period. As per the Joint Research Commission’s report of European Commission released in July 2020, it was estimated that in 2020 about 2.7 million (excluding non-melanoma cancer) new cancer cases would be diagnosed in the European Union, and breast cancer will be the most prevalent form of cancer with about 355,000 new cases in 2020. Moreover, growing prevalence of chronic kidney disorders are expected to create lucrative growth during the forecast period. Furthermore, growing demand for analysing of tumors by identification of enzymes, tumor specific antigens, tumor suppressor genes, oncogenes and tumor cell proliferation markers is expected to enhance demand for immunohistochemistry market during the forecast period. Moreover, growing incidence of cardiovascular diseases, heart diseases, asthma, and chronic obstructive pulmonary diseases along with rising number of patient visits in the hospitals can enhance the demand for immunohistochemistry market during the forecast period.

Growing Demand for Personalized Medicine

The growing demand for personalized medicine for non-small cell lung cancer patients enhanced the demand for immunohistochemistry during the forecast period. Moreover, this technique helps in making appropriate treatment decision by performing the most complete and accurate histological subtyping tumors possible which can enhance the demand for the market over the years. Similarly, growing availability of immunohistochemistry assays that can detect mutant proteins such as BRAF V600E and IDH1 R132H will further drive the market during the forecast period. It can provide a helpful replacement or adjunct for molecular testing. These techniques are highly reproducible with entail reasonable technical and interpretation complexity and is also available at lesser costs. Growing development of multiplex and mutation specific immunohistochemistry assays represents important innovations which is expected to further drive the growth of the market during the forecast period. According to research published in the Laboratory Investigation journal in July 2020, the immunohistochemical (IHC) and in situ hybridization (ISH) assays were utilized for detecting Covid-19 infection.

Download Free Sample Report

Market Segmentation

Global Immunohistochemistry market can be segmented on the basis of product, application, end user, and by region. Based on product, the market can be segmented into antibodies, equipment, reagents, and kits. On the basis of application, the market can be segmented into diagnostics, drug testing, and forensic applications. Based on end user, the market can be further divided into hospitals & diagnostic laboratories, research institutes, and others. On the basis of region, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, the United States dominated the global immunohistochemistry market on account of the growing prevalence of chronic diseases in the country.

Recent Development

In June 2022, Roche launched HPV self-sampling solution and expanding cervical cancer screening options.

In February 2022, Moderna and Thermo Fisher Scientific announced long term strategic collaboration for manufacturing of Spikevax vaccine in the U.S. for diagnosis of COVID-19 and other investigational mRNA medicines in this pipeline.

In February 2022, new genetic analyzer brought advanced capabilities to sanger sequencing and fragment analysis which is called as capillary electrophoresis and it enables sanger sequencing and fragment analysis, which is essential for improving clinical research and advancing scientific discovery.

Market Players

Thermo Fisher Scientific Inc., F.Hoffmann-La Roche Ltd., Merck KGaA., Danaher Corporation., Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology Inc., Bio SB., Agilent Technologies, Inc. are some of the leading players operating in the global Immunohistochemistry market.

Attribute	Details
Base Year	2022
Historic Data	2018 – 2021
Estimated Year	2023
Forecast Period	2024 – 2028
Quantitative Units	Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
Report Coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments Covered	By Product By Application By End User By Region
Regional scope	North America, Europe, Asia Pacific, South America, Middle East & Africa
Country scope	United States, Canada, Mexico, France, Germany, United Kingdom, Italy, Spain, China, India, Japan, South Korea, Australia, Brazil, Argentina, Colombia, South Africa, Saudi Arabia, UAE
Key companies profiled	Thermo Fisher Scientific Inc., F.Hoffmann-La Roche Ltd., Merck KGaA., Danaher Corporation., Perkinelmer, Inc., Bio-Rad Laboratories, Inc., Cell Signaling Technology Inc., Bio SB., Agilent Technologies, Inc.
Customization scope	10% free report customization with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, global Immunohistochemistry market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

· Immunohistochemistry Market, By Product:

o Antibodies

o Equipment

o Reagents

o Kits

· Immunohistochemistry Market, By Application:

o Diagnostics

o Drug Testing

o Forensic applications

· Immunohistochemistry Market, By End User:

o Hospitals & Diagnostic Laboratories

o Research Institutes

o Others

· Immunohistochemistry Market, By Region:

o North America

§ United States

§ Canada

§ Mexico

o Europe

§ France

§ Germany

§ United Kingdom

§ Italy

§ Spain

o Asia Pacific

§ China

§ India

§ Japan

§ South Korea

§ Australia

o South America

§ Brazil

§ Argentina

§ Colombia

o Middle East & Africa

§ South Africa

§ Saudi Arabia

§ UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Immunohistochemistry Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Global Immunohistochemistry Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1. Product Overview

1.1. Market Definition

1.2. Scope of the Market

1.2.1. Markets Covered

1.2.2. Years Considered for Study

1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study

2.2. Baseline Methodology

2.3. Key Industry Partners

2.4. Major Association and Secondary Sources

2.5. Forecasting Methodology

2.6. Data Triangulation & Validation

2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market

3.2. Overview of Key Market Segmentations

3.3. Overview of Key Market Players

3.4. Overview of Key Regions/Countries

3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Immunohistochemistry Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value

5.2. Market Share & Forecast

5.2.1. By Product (Antibodies, Equipment, Reagents, Kits)

5.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)

5.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)

5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

5.2.5. By Company (2022)

5.3. Market Map

5.3.1 By Product

5.3.2 By Application

5.3.3 By End User

5.3.4 By Region

6. North America Immunohistochemistry Market Outlook

6.1. Market Size & Forecast

6.1.1. By Value

6.2. Market Share & Forecast

6.2.1. By Product (Antibodies, Equipment, Reagents, Kits)

6.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)

6.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)

6.2.4. By Country

6.3. North America: Country Analysis

6.3.1. United States Immunohistochemistry Market Outlook

6.3.1.1. Market Size & Forecast

6.3.1.1.1. By Value

6.3.1.2. Market Share & Forecast

6.3.1.2.1. By Product

6.3.1.2.2. By Application

6.3.1.2.3. By End User

6.3.2. Canada Immunohistochemistry Market Outlook

6.3.2.1. Market Size & Forecast

6.3.2.1.1. By Value

6.3.2.2. Market Share & Forecast

6.3.2.2.1. By Product

6.3.2.2.2. By Application

6.3.2.2.3. By End User

6.3.3. Mexico Immunohistochemistry Market Outlook

6.3.3.1. Market Size & Forecast

6.3.3.1.1. By Value

6.3.3.2. Market Share & Forecast

6.3.3.2.1. By Product

6.3.3.2.2. By Application

6.3.3.2.3. By End User

7. Europe Immunohistochemistry Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Product (Antibodies, Equipment, Reagents, Kits)

7.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)

7.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)

7.2.4. By Country

7.3. Europe: Country Analysis

7.3.1. France Immunohistochemistry Market Outlook

7.3.1.1. Market Size & Forecast

7.3.1.1.1. By Value

7.3.1.2. Market Share & Forecast

7.3.1.2.1. By Product

7.3.1.2.2. By Application

7.3.1.2.3. By End User

7.3.2. Germany Immunohistochemistry Market Outlook

7.3.2.1. Market Size & Forecast

7.3.2.1.1. By Value

7.3.2.2. Market Share & Forecast

7.3.2.2.1. By Product

7.3.2.2.2. By Application

7.3.2.2.3. By End User

7.3.3. United Kingdom Immunohistochemistry Market Outlook

7.3.3.1. Market Size & Forecast

7.3.3.1.1. By Value

7.3.3.2. Market Share & Forecast

7.3.3.2.1. By Product

7.3.3.2.2. By Application

7.3.3.2.3. By End User

7.3.4. Italy Immunohistochemistry Market Outlook

7.3.4.1. Market Size & Forecast

7.3.4.1.1. By Value

7.3.4.2. Market Share & Forecast

7.3.4.2.1. By Product

7.3.4.2.2. By Application

7.3.4.2.3. By End User

7.3.5. Spain Immunohistochemistry Market Outlook

7.3.5.1. Market Size & Forecast

7.3.5.1.1. By Value

7.3.5.2. Market Share & Forecast

7.3.5.2.1. By Product

7.3.5.2.2. By Application

7.3.5.2.3. By End User

8. Asia-Pacific Immunohistochemistry Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Product (Antibodies, Equipment, Reagents, Kits)

8.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)

8.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)

8.2.4. By Country

8.3. Asia-Pacific: Country Analysis

8.3.1. China Immunohistochemistry Market Outlook

8.3.1.1. Market Size & Forecast

8.3.1.1.1. By Value

8.3.1.2. Market Share & Forecast

8.3.1.2.1. By Product

8.3.1.2.2. By Application

8.3.1.2.3. By End User

8.3.2. India Immunohistochemistry Market Outlook

8.3.2.1. Market Size & Forecast

8.3.2.1.1. By Value

8.3.2.2. Market Share & Forecast

8.3.2.2.1. By Product

8.3.2.2.2. By Application

8.3.2.2.3. By End User

8.3.3. Japan Immunohistochemistry Market Outlook

8.3.3.1. Market Size & Forecast

8.3.3.1.1. By Value

8.3.3.2. Market Share & Forecast

8.3.3.2.1. By Product

8.3.3.2.2. By Application

8.3.3.2.3. By End User

8.3.4. South Korea Immunohistochemistry Market Outlook

8.3.4.1. Market Size & Forecast

8.3.4.1.1. By Value

8.3.4.2. Market Share & Forecast

8.3.4.2.1. By Product

8.3.4.2.2. By Application

8.3.4.2.3. By End User

8.3.5. Australia Immunohistochemistry Market Outlook

8.3.5.1. Market Size & Forecast

8.3.5.1.1. By Value

8.3.5.2. Market Share & Forecast

8.3.5.2.1. By Product

8.3.5.2.2. By Application

8.3.5.2.3. By End User

9. South America Immunohistochemistry Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Product (Antibodies, Equipment, Reagents, Kits)

9.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)

9.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)

9.2.4. By Country

9.3. South America: Country Analysis

9.3.1. Brazil Immunohistochemistry Market Outlook

9.3.1.1. Market Size & Forecast

9.3.1.1.1. By Value

9.3.1.2. Market Share & Forecast

9.3.1.2.1. By Product

9.3.1.2.2. By Application

9.3.1.2.3. By End User

9.3.2. Argentina Immunohistochemistry Market Outlook

9.3.2.1. Market Size & Forecast

9.3.2.1.1. By Value

9.3.2.2. Market Share & Forecast

9.3.2.2.1. By Product

9.3.2.2.2. By Application

9.3.2.2.3. By End User

9.3.3. Colombia Immunohistochemistry Market Outlook

9.3.3.1. Market Size & Forecast

9.3.3.1.1. By Value

9.3.3.2. Market Share & Forecast

9.3.3.2.1. By Product

9.3.3.2.2. By Application

9.3.3.2.3. By End User

10. Middle East and Africa Immunohistochemistry Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Product (Antibodies, Equipment, Reagents, Kits)

10.2.2. By Application (Diagnostics, Drug Testing, Forensic applications)

10.2.3. By End User (Hospitals & Diagnostic Laboratories, Research Institutes, Others)

10.2.4. By Country

10.3. MEA: Country Analysis

10.3.1. South Africa Immunohistochemistry Market Outlook

10.3.1.1. Market Size & Forecast

10.3.1.1.1. By Value

10.3.1.2. Market Share & Forecast

10.3.1.2.1. By Product

10.3.1.2.2. By Application

10.3.1.2.3. By End User

10.3.2. Saudi Arabia Immunohistochemistry Market Outlook

10.3.2.1. Market Size & Forecast

10.3.2.1.1. By Value

10.3.2.2. Market Share & Forecast

10.3.2.2.1. By Product

10.3.2.2.2. By Application

10.3.2.2.3. By End User

10.3.3. UAE Immunohistochemistry Market Outlook

10.3.3.1. Market Size & Forecast

10.3.3.1.1. By Value

10.3.3.2. Market Share & Forecast

10.3.3.2.1. By Product

10.3.3.2.2. By Application

10.3.3.2.3. By End User

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

12.1. Recent Development

12.2. Mergers & Acquisitions

12.3. Product Launches

13. Global Immunohistochemistry Market: SWOT Analysis

14. Porter’s Five Forces Analysis

14.1. Competition in the Industry

14.2. Potential of New Entrants

14.3. Power of Suppliers

14.4. Power of Customers

14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Business Overview

15.2. Product Offerings

15.3. Recent Developments

15.4. Financials (As Reported)

15.5. Key Personnel

15.6. SWOT Analysis

15.6.1 Thermo Fisher Scientific Inc.

15.6.2 F.Hoffmann-La Roche Ltd.

15.6.3 Merck KGaA.

15.6.4 Danaher Corporation.

15.6.5 Perkinelmer, Inc.

15.6.6 Bio-Rad Laboratories, Inc.

15.6.7 Cell Signaling Technology Inc.

15.6.8 Bio SB.

15.6.9 Agilent Technologies, Inc.

15.6.10 Abcam Plc.

16. Strategic Recommendations

Figures and Tables

Frequently asked questions

What are the major drivers for the Global Immunohistochemistry Market?

The rise in the prevalence of chronic diseases and the increase in the geriatric population in developed nations along with growing research & development activities in immunohistochemistry are some of the major factors driving the growth of the global Immunohistochemistry market.

Related Reports

Sakshi Bajaal

Business Consultant

Talk To Analyst

Press Release

Immunohistochemistry Market to be Dominated by Antibodies Through 2028

Feb, 2023

The growing prevalence of chronic and infectious diseases is expected to drive the growth of the Global Immunohistochemistry market during the forecast period, 2024-2028.